The company will hold a conference call with management on Tuesday, Sept. 3 VANCOUVER, British Columbia and PHOENIX, Aug. 29, 2019 /PRNewswire/ -- 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), announces the interim unaudited financial result

VAUGHAN, ON, Aug. 29, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which require the Company to provide bi-weekly upda

ARLINGTON, Va., Aug. 29, 2019 /PRNewswire/ -- March of Dimes today released the following statement from Rahul Gupta, MD, MPH, MBA, FACP, Chief Medical & Health Officer, Senior Vice President, in response to the release of the

NEW BRUNSWICK, N.J., Aug. 29, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The Grand Hyatt Hotel in New York.  Peter F. Lebowitz, M.D., Ph.D. Global

SANTA CLARA, Calif., Aug. 29, 2019 /PRNewswire/ -- Today eHealth, Inc. (NASDAQ: EHTH) (eHealth.com) announced that Beth A. Brooke has been appointed an independent direct

COLUMBUS, Ga., Aug. 29, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that Gerardo Monroy has been named senior vice president, Aflac U.S. Innovation Strategy and Execution, reporting to Virgil R. Miller, executive vice president; chief operating officer, Aflac U.S.; pr

LA JOLLA, Calif., Aug. 29, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development o

FORT WORTH, Texas, Aug. 29, 2019 /PRNewswire/ -- Mark Lashley, President and CEO of Caregiver, Inc., a leading provider of services to adults with intellectual and developmental disabilities (IDD), has announced that Randi Morgan, RN, has been promoted to the role of Executive Director of Clinical, Quality and Compliance, a new positio

ALAMEDA, Calif., Aug. 29, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the promotion of Sri Kosaraju to President, in addition to his current responsibilities as CFO of Penumbra. Kosaraju joined Penumbra as chief financial off

PALO ALTO, Calif., Aug. 29, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will participate in the following upcoming investor conferences in September:Baird 2019 Global Healthcare